Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Shares Issued (2016 - 2025)

Lipocine (LPCN) has disclosed Shares Issued for 11 consecutive years, with $141334.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued changed N/A year-over-year to $141334.0, compared with a TTM value of $136035.0 through Sep 2025, down 25.53%, and an annual FY2024 reading of $209340.0, down 48.26% over the prior year.
  • Shares Issued was $141334.0 for Q3 2025 at Lipocine, up from -$5299.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $26.8 million in Q1 2021 and bottomed at -$26.8 million in Q2 2021.
  • Average Shares Issued over 4 years is $2.7 million, with a median of $73339.0 recorded in 2022.
  • The sharpest move saw Shares Issued crashed 2252.24% in 2021, then surged 7779.53% in 2023.
  • Year by year, Shares Issued stood at $26.8 million in 2021, then crashed by 100.87% to -$233123.0 in 2022, then skyrocketed by 97.73% to -$5299.0 in 2023, then surged by 2767.18% to $141334.0 in 2025.
  • Business Quant data shows Shares Issued for LPCN at $141334.0 in Q3 2025, -$5299.0 in Q4 2023, and $421082.0 in Q3 2023.